These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15495191

  • 1. Homozygous deletions of CDKN2A caused by alternative mechanisms in various human cancer cell lines.
    Raschke S, Balz V, Efferth T, Schulz WA, Florl AR.
    Genes Chromosomes Cancer; 2005 Jan; 42(1):58-67. PubMed ID: 15495191
    [Abstract] [Full Text] [Related]

  • 2. Peculiar structure and location of 9p21 homozygous deletion breakpoints in human cancer cells.
    Florl AR, Schulz WA.
    Genes Chromosomes Cancer; 2003 Jun; 37(2):141-8. PubMed ID: 12696062
    [Abstract] [Full Text] [Related]

  • 3. Fine-mapping loss of gene architecture at the CDKN2B (p15INK4b), CDKN2A (p14ARF, p16INK4a), and MTAP genes in head and neck squamous cell carcinoma.
    Worsham MJ, Chen KM, Tiwari N, Pals G, Schouten JP, Sethi S, Benninger MS.
    Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):409-15. PubMed ID: 16618910
    [Abstract] [Full Text] [Related]

  • 4. Molecular processes of chromosome 9p21 deletions in human cancers.
    Sasaki S, Kitagawa Y, Sekido Y, Minna JD, Kuwano H, Yokota J, Kohno T.
    Oncogene; 2003 Jun 12; 22(24):3792-8. PubMed ID: 12802286
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Detecting homozygous deletions in the CDKN2A(p16(INK4a))/ARF(p14(ARF)) gene in urinary bladder cancer using real-time quantitative PCR.
    Berggren P, Kumar R, Sakano S, Hemminki L, Wada T, Steineck G, Adolfsson J, Larsson P, Norming U, Wijkström H, Hemminki K.
    Clin Cancer Res; 2003 Jan 12; 9(1):235-42. PubMed ID: 12538475
    [Abstract] [Full Text] [Related]

  • 7. Molecular processes of chromosome 9p21 deletions causing inactivation of the p16 tumor suppressor gene in human cancer: deduction from structural analysis of breakpoints for deletions.
    Kohno T, Yokota J.
    DNA Repair (Amst); 2006 Sep 08; 5(9-10):1273-81. PubMed ID: 16931177
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Prognostic significance of homozygous deletions and multiple duplications at the CDKN2A (p16INK4a)/ARF (p14ARF) locus in urinary bladder cancer.
    Berggren de Verdier PJ, Kumar R, Adolfsson J, Larsson P, Norming U, Onelöv E, Wijkström H, Steineck G, Hemminki K.
    Scand J Urol Nephrol; 2006 Sep 08; 40(5):363-9. PubMed ID: 17060081
    [Abstract] [Full Text] [Related]

  • 10. CDKN2A/p16 is inactivated in most melanoma cell lines.
    Castellano M, Pollock PM, Walters MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG, Hayward NK.
    Cancer Res; 1997 Nov 01; 57(21):4868-75. PubMed ID: 9354451
    [Abstract] [Full Text] [Related]

  • 11. Early acquisition of homozygous deletions of p16/p19 during squamous cell carcinogenesis and genetic mosaicism in bladder cancer.
    Tsutsumi M, Tsai YC, Gonzalgo ML, Nichols PW, Jones PA.
    Oncogene; 1998 Dec 10; 17(23):3021-7. PubMed ID: 9881704
    [Abstract] [Full Text] [Related]

  • 12. CDKN2A, CDKN2B, and MTAP gene dosage permits precise characterization of mono- and bi-allelic 9p21 deletions in childhood acute lymphoblastic leukemia.
    Bertin R, Acquaviva C, Mirebeau D, Guidal-Giroux C, Vilmer E, Cavé H.
    Genes Chromosomes Cancer; 2003 May 10; 37(1):44-57. PubMed ID: 12661005
    [Abstract] [Full Text] [Related]

  • 13. Homozygous deletions of the INK4a/ARF locus in renal cell cancer.
    Kasahara T, Bilim V, Hara N, Takahashi K, Tomita Y.
    Anticancer Res; 2006 May 10; 26(6B):4299-305. PubMed ID: 17201148
    [Abstract] [Full Text] [Related]

  • 14. Homozygous deletions of methylthioadenosine phosphorylase (MTAP) are more frequent than p16INK4A (CDKN2) homozygous deletions in primary non-small cell lung cancers (NSCLC).
    Schmid M, Malicki D, Nobori T, Rosenbach MD, Campbell K, Carson DA, Carrera CJ.
    Oncogene; 1998 Nov 19; 17(20):2669-75. PubMed ID: 9840931
    [Abstract] [Full Text] [Related]

  • 15. A methylthioadenosine phosphorylase (MTAP) fusion transcript identifies a new gene on chromosome 9p21 that is frequently deleted in cancer.
    Schmid M, Sen M, Rosenbach MD, Carrera CJ, Friedman H, Carson DA.
    Oncogene; 2000 Nov 23; 19(50):5747-54. PubMed ID: 11126361
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes.
    Bloethner S, Hemminki K, Thirumaran RK, Chen B, Mueller-Berghaus J, Ugurel S, Schadendorf D, Kumar R.
    Melanoma Res; 2006 Aug 23; 16(4):297-307. PubMed ID: 16845325
    [Abstract] [Full Text] [Related]

  • 18. Chromosome 9p21 gene copy number and prognostic significance of p16 in ESFT.
    Brownhill SC, Taylor C, Burchill SA.
    Br J Cancer; 2007 Jun 18; 96(12):1914-23. PubMed ID: 17533400
    [Abstract] [Full Text] [Related]

  • 19. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
    Thompson PM, Maris JM, Hogarty MD, Seeger RC, Reynolds CP, Brodeur GM, White PS.
    Cancer Res; 2001 Jan 15; 61(2):679-86. PubMed ID: 11212268
    [Abstract] [Full Text] [Related]

  • 20. Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions.
    Pollock PM, Pearson JV, Hayward NK.
    Genes Chromosomes Cancer; 1996 Feb 15; 15(2):77-88. PubMed ID: 8834170
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.